论文部分内容阅读
目的观察雾化吸入联合孟鲁司特钠治疗小儿因感染后咳嗽的临床疗效。方法选取2010年1月至2010年12月原阳县红十字医院收治的62例感染后咳嗽患儿,并将其随机分为观察组与对照组,每组31例。对照组采用孟鲁司特钠咀嚼片进行治疗,观察组在此基础上加布地奈德雾化吸入剂进行联合治疗,比较两组患儿的临床效果及用药安全性。结果观察组治疗有效率为90.3%,对照组为77.4%,观察组治疗效果明显优于对照组,差异有统计学意义(P<0.05)。且两组患儿均未出现明显的不良反应,用药安全性较高。结论雾化吸入联合孟鲁司特钠治疗因感染而引起的小儿咳嗽效果显著,且该种药物组合安全性较高,值得在临床上广泛推广,帮助更多患儿受益。
Objective To observe the clinical effect of inhalation combined with montelukast sodium on children with cough after infection. Methods Sixty-two children with post-infection cough from January 2010 to December 2010 in Red Cross Hospital of Yuanyang County were randomly divided into observation group and control group, with 31 cases in each group. The control group was treated with montelukast sodium chewable tablets. On the basis of this, the observation group was given Budesonide inhalation for combination therapy. The clinical effect and safety of the two groups were compared. Results The effective rate of observation group was 90.3%, while that of the control group was 77.4%. The observation group had better treatment effect than the control group (P <0.05). And two groups of children did not appear obvious adverse reactions, medication safety higher. Conclusion Inhaled inhalation combined with montelukast sodium treatment of children with cough caused by infection is significant, and the combination of high safety of the drug, it is worth widely clinically to help more children benefit.